The
New England Journal of Medicine will publish two papers demonstrating
the effectiveness of Geron Corp.'s (Nasdaq: GERN) imetelstat. The stock price gained 40 cents to close at $3.45.
Papers on Geron's imetelstat to be published
September 03, 2015 at 17:50 PM EDT
